{"id":"NCT04285515","sponsor":"Intra-Cellular Therapies, Inc.","briefTitle":"Clinical Trial Evaluating Lumateperone Monotherapy in the Treatment of Bipolar Depression or Major Depressive Disorder","officialTitle":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Lumateperone Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder (Bipolar Depression) or Major Depressive Disorder","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-02-27","primaryCompletion":"2022-11-30","completion":"2022-11-30","firstPosted":"2020-02-26","resultsPosted":"2025-03-19","lastUpdate":"2025-03-19"},"enrollment":488,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Bipolar Depression","Major Depressive Disorder"],"interventions":[{"type":"DRUG","name":"Lumateperone","otherNames":[]},{"type":"DRUG","name":"Placebos","otherNames":[]}],"arms":[{"label":"Lumateperone 42mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of lumateperone monotherapy in the treatment of patients with major depressive episodes associated with Bipolar I or Bipolar II Disorder (Bipolar Depression) or major depressive disorder (MDD) who also meet the Diagnostic and Statistical Manual of Mental Disorder, 5th Edition (DSM-5) criteria for mixed-features. The study consists of a Screening Period, a Double-blind Treatment Period, and a Safety Follow-up Period.","primaryOutcome":{"measure":"Change From Baseline in Montgomery-Ã…sberg Depression Rating Scale (MADRS) Total Score","timeFrame":"Day 43","effectByArm":[{"arm":"Lumateperone 42mg","deltaMin":-18.1,"sd":0.71},{"arm":"Placebo","deltaMin":-12.4,"sd":0.7}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":4},"locations":{"siteCount":42,"countries":["United States","Bulgaria","Russia","Serbia","Ukraine"]},"refs":{"pmids":["39946099"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":240},"commonTop":["Headache","Somnolence","Dizziness","Nausea"]}}